These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1988082)
1. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1). Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082 [TBL] [Abstract][Full Text] [Related]
2. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4. Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671 [TBL] [Abstract][Full Text] [Related]
4. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells. Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980 [TBL] [Abstract][Full Text] [Related]
5. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen. Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980 [TBL] [Abstract][Full Text] [Related]
9. Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant. Hand PH; Calvo B; Milenic D; Yokota T; Finch M; Snoy P; Garmestani K; Gansow O; Schlom J; Kashmiri SV Cancer Immunol Immunother; 1992; 35(3):165-74. PubMed ID: 1638552 [TBL] [Abstract][Full Text] [Related]
10. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas. Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354 [TBL] [Abstract][Full Text] [Related]
11. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system. Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752 [TBL] [Abstract][Full Text] [Related]
12. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797 [TBL] [Abstract][Full Text] [Related]
13. Chimeric anti-ganglioside GM2 antibody with antitumor activity. Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257 [TBL] [Abstract][Full Text] [Related]
14. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2. Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions. Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683 [TBL] [Abstract][Full Text] [Related]
16. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107 [TBL] [Abstract][Full Text] [Related]
17. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody. Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725 [TBL] [Abstract][Full Text] [Related]
18. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential. Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300 [TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody. Xiang J; Chen Z Immunology; 1992 Feb; 75(2):209-16. PubMed ID: 1551684 [TBL] [Abstract][Full Text] [Related]
20. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]